Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Collaborative and Cybridi to Co-Develop Breast Cancer Tissue Array

NEW YORK, April 6 (GenomeWeb News) - Genomics Collaborative and Cybrdi will co-develop a breast tumor tissue microarray, the companies said today.

 

The arrays will be accompanied by clinical data on the molecular factors of the tissue to "establish correlations between the severity of the disease, responses to treatments, and the presence of certain biomarkers," Larry Liu, president and CEO of Cybrdi, said in the statement. "It can be expanded to other types of malignancies, including colon, lung, and brain tumors."

 

Genomics Collaborative, a division of SeraCare Life Science, is providing tissue from its GC Global Repository samples, which are linked to clinical, demographic, and treatment data.

 

"We hope to generate additional tumor-specific tissue arrays that look at the tissue's response to treatment," said Kevin Krenitsky, Genomics Collaborative senior vice president, in the statement.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.